Probiotics may reduce risk of VAP in ICU patients

06/17/2010 | Science Blog

Daily probiotic therapy halved the risk of ventilator-associated pneumonia in a select group of patients in the intensive care unit, U.S. researchers found. The study, which used twice-daily doses of Lactobacillus rhamnosus, also showed that the treatment reduced the amount of antibiotics needed after almost five years.

View Full Article in:

Science Blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA